Bioleaders Corporation announced a private placement of series 9 bearer type unguaranteed private equity exchange bonds for gross proceeds of KRW 8,000,000,000 on November 29, 2021. The company expects to close the transaction on December 1, 2021. The transaction was approved by the board of directors of the company.